Newcastle University · company speakers →
John Burn, MD, discussed the CaPP3 study on aspirin for cancer prevention in Lynch syndrome.
Is this you? Claim this profile →
No public contact links on file.
Speaking history
AACR Special Conference: Advances in the Pathogenesis and Immune Therapies of Liver Cancer
AACR Drug Discovery and Development (AACR D3)
Sourcing speakers for your event?
Browse the speaker directory →